NVUS Shares Outstanding History



Below is a table of the NVUS shares outstanding history going back to 5/11/2017:

Date NVUS Shares Outstanding
5/11/2017139763
8/4/2017385726
11/6/2017393634
3/23/2018522612
5/7/2018522612
8/3/2018523452
11/8/2018523452
3/22/2019524125
5/10/2019716471
8/12/2019720829
11/11/2019720408
3/9/2020892753
5/11/2020892753
8/11/20201.08M
10/5/20201.08M
11/13/20201.43M

Also see: NVUS Market Cap History
NVUS YTD Return
NVUS Historical Shares Outstanding:
+93.94% CAGR
NVUS Historical Shares Outstanding: +93.94% CAGR

Mouse over chart for data details
5/11/2017 ...11/13/2020
Novus Therapeutics is a pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat. Co. has two platform technologies, a surfactant and a foam. Co.'s primary program, OP0201, is a surfactant-based nasal aerosol drug-device combination product candidate being developed as a treatment option for patients at risk for, or with, otitis media (OM). OM is defined as middle ear inflammation and effusion with or without infection. Co. also has a foam-based drug delivery technology platform, which may be developed to deliver drugs into the ear, nasal, and sinus cavities. We show 16 historical shares outstanding datapoints in our coverage of NVUS's shares outstanding history.

Understanding the changing numbers of NVUS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NVUS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NVUS by allowing them to research NVUS shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree NVUS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Novus Therapeutics (NVUS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

NXGL Shares Outstanding History
NXL Shares Outstanding History
NXTC Shares Outstanding History
NXTM Shares Outstanding History
NYMX Shares Outstanding History
OBLN Shares Outstanding History
OCGN Shares Outstanding History
OCUL Shares Outstanding History
OCUP Shares Outstanding History
OCX Shares Outstanding History
More Healthcare companies »

 

NVUS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.